2010 Southeast Region
Technology Transfer
Director’s Meeting
7.30.2010
Scott Sewell
Vice President Technology Acquisition & Development
Early Beginnings
Bloomington, Indiana
Overview
• Cook established in 1963 – offers three products
• Today, 15,000+ products, 9,000+ employees worldwide,
16 medical entities, manufacturing on three continents,
nine (9) strategic business units (SBUs), 2 shared
service centers, distribution into more than 135 countries
across more than 35 regulatory regions
• Global representation interacting with 42 medical
specialties focused on development of minimallyinvasive and converging medical technologies
(Devices, Biotechnology, Biopharma and Cell Therapy)
Business Unit Focus
•
Aortic Intervention
–
Interventional technologies providing endovascular solutions for cardiovascular
disease affecting aorta and its branch vessels
- Vascular Surgery
- Thoracic Surgery
•
Lead Management
–
A stand alone business emerging from Peripheral and Aortic Intervention
- Electrophysiology
- Cardiology
•
Critical Care
–
Antibiotic-Impregnated central venous catheters, difficult airway management devices.
- Anesthesia
- Critical Care Medicine
- Emergency Medicine
- Pulmonary Medicine
- Pediatrics/Neonatology
•
Endoscopy
–
Interventional technologies that enhance efficient diagnoses and provide effective treatment
for patients with biliary, pancreatic and esophageal/colonic/gastric diseases
- Gastroenterology
•
Business Unit Focus
Peripheral Intervention
Vascular and non vascular access and treatment technologies supporting medical outcomes-based
interventional procedures in radiology, neuroradiology and vascular surgery
- Interventional Radiology
- Interventional Cardiology
- Vascular Surgery
•
Surgery
Biodesigned regenerative scaffold technology used to signal the body to remodel weakened or
damaged soft tissue.
- General Surgery
- Colo-Rectal Surgery
- Plastic/Reconstructive Surgery
- Neurosurgery
- Reconstructive Microsurgery
•
Urology
Interventional and biodesigned technologies focusing on adult and pediatric urology with an emphasis
on stone management and pelvic health
- Urology
•
Women’s Health
Technologies to support reproduction, high risk obstetric and gynecologic procedures and incontinence
- Obstetrics
- Gynecology
- Embryology
Core Technologies
• BIOPHARMA -
Cutting edge technology to enhance the development and
delivery of vaccines and therapies. These are mammalian cell “factories” to produce
the antibodies that deliever the targeted medicine.
• Biotech – Biodesigned regenerative scaffold used to signal the body to remodel
weakend or damaged soft tissue while providing long term strength and support.
• Gene Therapy – Antisense, a gene –therapy compound that targets key genes
responsible for cell migration and adhesion, collagen formation, secretion of
extracellular matrix with potential use in drug eluting stents.
• Cell Therapy – Extracting and deriving muscle-derived cells, this technology is
used to treat various conditions where tissues have grown weak or lost their initial
function.
Unique Technologies
Biotechnology
Dural Graft
Anal Fistula Plug
Staple Line
Reinforcement
Aortic Aneurysm Repair
Drug Eluting Stents
Antibiotic Impregnated Catheters
Spectrum Technology
Winston-Salem, North Carolina
In 1983, Don Wilson and Bill Cook saw the need for minimally
invasive devices in the growing field of gastroenterology.
Bill Cook
Don Wilson
Over 45 years of experience developing devices
Our Process in a nutshell:
1.
Gather ideas from a variety
of sources
2.
Establish clinical development
partners (clinicians with interest
and expertise in the selected
device area)
3.
Develop a detailed understanding
of the problem and
proposed solution(s)
4.
Evaluate prototypes
5.
FDA Filing
6.
Limited release/evaluation
7.
Full release
At the Forefront of Research
and Development
We have a successful
history of commercializing
devices and have the
infrastructure and
knowledge to support
research projects such as
NOTES to become a reality
Cook is dedicated to
bold leadership in pioneering
innovative medical solutions
to enhance patient care worldwide.
– mission statement